Tirzepatide banned - Blue Ridge Meds

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/blueridgemeds/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-gateway-authorize-net-cim domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/blueridgemeds/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the metorik domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/blueridgemeds/wp-includes/functions.php on line 6121
Tirzepatide banned - Blue Ridge Meds

$50 OFF Any Dosage | $100 Off for New GLP-1 Users

Breaking News:

Compounded Tirzepatide is no longer available nationwide

[10/02/2024 7:04 pm EDT]

The U.S. Food and Drug Administration (FDA) has announced that tirzepatide, the active ingredient in name brand medications Mounjaro® and Zepbound®, has been removed from the drug shortage list, which means compounding pharmacies are now prohibited from producing this medication under federal guidelines.

As a result, BlueRidge Meds can no longer offer access to pharmacies to fulfill compounded tirzepatide prescriptions.

We understand that this might be concerning, especially for those of you who have relied on this affordable option as part of your weight loss journey.

We want to reassure you that we are committed to providing a seamless transition and continuing your access to effective treatments.